Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 404-410

  Wojcik, Walter J ^a   Swoveund, Peggy ^a   Zhang, Xiaofeng ^a   Vanguri, Padmavathy ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MYELIN BASIC PROTEIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; ORGANOPHOSPHATE; PROTEIN; PROTEIN CRG 2; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; HINDLIMB; INTRATHECAL DRUG ADMINISTRATION; LUMBAR SPINAL CORD; MALE; NONHUMAN; OSMOTIC MINIPUMP; PARALYSIS; PRIORITY JOURNAL; RAT; SUBARACHNOID SPACE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INJECTIONS, SPINAL; MALE; MONOKINES; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, INBRED LEW; RNA, MESSENGER; SPINAL CORD;

EID: 0030431342     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. BENVENISTE, E. N.: Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am. J. Physiol. 263: C1-C15, 1992.
2. CHIASSON, B. J., HOOPER, M. L., MURPHY, P. R. AND ROBERTSON, H. A.: Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain, Eur. J. Pharmacol. 227: 451-153, 1992.
3. CHIASSON, B. J., ARMSTRONG, J. N., HOOPER, M. L., MURPHY, P. R. AND ROBERTSON, H. A.: The application of antisense oligonucleotide technology to the brain: Some pitfalls. Cell. Mol. Neurobiol. 14: 507-521, 1994.
4. COOK, D. P.: Medicinal chemistry strategies for antisense research. In Antisense Research and Applications, edited by S. T. Crooke and B. Lebleu, pp. 149-187, CRC Press, Boca Raton, FL, 1993.
5. CROOKE, S. T.: Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 7: 533-539, 1993.
6. DEIBLER, G. E., MARTENSON, R. E. AND KIES, M. W.: Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2: 139-165, 1972.
7. FONTANA, A., FIERZ, W. AND WEKERLE, H.: Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307: 273-276, 1984.
8. FREI, K., SIEPL, C., GROSCURTH, P., BODMER, S., SCHWERDEL, C. AND FOOTANA, A.: Antigen presentation and tumor cytotoxicity by interferon-G-treated microglial cells. Eur. J. Immunol. 17: 1271-1278, 1987.
9. GODISKA, R., CHANTRY, D., DIETSCH, G. N. AND GRAY, P. W.: Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167-176, 1995.
10. HAMMOND, D.: Intrathecal administration: methodological considerations. Progr. Brain Res. 77: 313-320, 1988.
11. HEBEL, H. AND STROMBERG, M. W.: In Anatomy of Laboratory Rat. William & Wilkins Co., Baltimore, 1976.
12. HICKEY, W. F. AND KIMURA, H.: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290-292, 1988.
13. HULKOWER, K., BROSNAN, C., AQUINO, D., CAMMER, W., KULSHRESHTA, S., GUIDA, M., RAPOPORT, D. AND BERMAN, J.: Expression of CSF-1, cfms and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150: 2525-2533, 1993.
14. KOJIMA, K., BEUGER, T., LASSMANN H., HINZE-SELCH, D., ZHANG, Y., GEHRMANN, J., RESKE, K., WEKERLE, H. AND LININGTON, C.: Experimental autoimmune panencephalitis and uveretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J. Exp. Med. 180: 817-829, 1994.
15. LININGTON, C., BERGER, T., PERRY, L., WEERTH, S., HINZE-SELCH, D., ZHANG, Y., LU, H.-C., LASSMANN, H. AND WEKERLE, H.: T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23: 1364-1372, 1993.
16. LIU, P. K., SALMINEN, A., HE, Y. Y., JIANG, M. H., XUE, J. J., LIU, J. S. AND HSU, C. Y.: Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA. Ann. Neurol. 36:566-576, 1994.
17. LONG J. B., MOBLEY, W. C. AND HOLADAY J. W.: Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses. J. Pharmacol. Exp. Ther. 246: 1158-1166, 1988.
18. LUSTER, A. D., UNKELESS, J. C. AND RAVETCH, J. V.: γ-interferon transcriptionally regulates an early response gene containing homology to platelet proteins. Nature 315: 672-676, 1985.
19. MATTHAEI, I., POLMAN, C. H., DEGROOT, C. J. A., DIJKSTRA, C. D., KOETSIER, J. C. AND SMINIA, T.: Observer agreement in the assessment of clinical signs in EAE. J. Neuroimmunol. 23: 25-32, 1989.
20. MERRIL, J. E., KONO, D. H., CLAYTON, J., ANDO, D. G., HINTON, D. R. AND HOFMAN, F. M.: Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10. PI mice. Proc. Natl. Acad. Sci. U.S.A. 89: 574-578, 1992.
21. MYERS, K. J., DOUGHERTY, J. P. AND RON, Y.: In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J. Immunol. 151: 2252-2260, 1993.
22. OPPENHEIM, J. J., ZACHARIAE, C. O. C., MUKAIDA, N. AND MATSUSHIMA, K.: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9: 617-648, 1991.
23. PARDRIDGE, W. M.: Transnasal and intraventricular delivery of drugs. In Peptide Drug Delivery to the Brain, Raven Press, New York, pp. 99-122, 1991.
24. PATERSON, P. Y. AND SWANBORG, R. H.: Demyelinating diseases of the Central and Peripheral Nervous System. In Immunological Diseases, 4th ed., ed. by M. Samter, pp. 1877-1916, Little Brown, Boston, MA, 1988.
25. RAINK, C. S.: Multiple sclerosis: TNF revisited with promise. Nature Med. 1: 211-214, 1995.
26. RACKE, M. K., DHIB-JALBUT, S., CANNELLA, B., ALBERT, P. S., RAINE, C. S. AND MCFARLIN, D. E.: Prevention and treatment of chronic relapsing experimental encephalomyelitis by transforming growth factor-β, J. Immunol. 146: 3012-3016, 1991.
27. RANSOHOFF, R. M., HAMILTON, T. A., TANI, M., STOLER, M. H., SHICK, H. E., MAJOR, J. A., ESTES, M. L., THOMAS, D. M. AND TUOHY, V. K.: Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7: 592-600, 1993.
28. RENNO, T., LIN, J. Y., PICCINILLO, C., ANTEL, J. AND OWENS, T.: Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49: 1-7, 1994.
29. ROSCOE, J. T.: The Mann-Whitney U-test, the t-test. In Fundamental Research Statistics for the Behavioral Sciences. Holt, Rinehart and Winston Inc., New York, pp. 230-237, 1975.
30. SEDHWICK, J., BROSTOFF, S. AND MASON, D.: Experimental allergic encephalomyelitis is the absence of a classical delayed-type hypersensitivity reaction. J. Exp. Med. 165: 1058-1075, 1987.
31. TAUB, D. D., LLOYD, A. R., CONLON, K., WANG, J. M., ORTALDO, J. R., HARADA, A., MATSUSHIMA, K., KELVIN, D. J. AND OPPENHEIM, J. J.: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177: 1809-1814, 1993.
32. VAN DER KROL, A. R., MOL, J. N. M. AND STUITJE, A. R.: Modulators of eukaryotic gene expression by complementary RNA and DNA sequences. Biotechniques 6: 958-976, 1988.
33. VANGURI, P. AND FARBER, J. M.: Identification of CRG-2: An interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265: 15049-15057, 1990.
34. VANGURI, P. AND FARBER, J. M.: Interferon and virus inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, Ia, in astrocytes and microglia. J. Immunol. 152:1411-1418, 1994.
35. WAHLESTEDT, C., PICH, E. M., KOOB, G. F., YEE, F. AND HEILIG, M.: Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides. Science 259: 528-531, 1993.
36. YAKSH, T. AND STEVENS, C. W.: Simple catheter preparation for permitting bolus intrathecal administration during chronic intrathecal infusion. Pharmacol. Biochem. Behav. 25: 483-485, 1986.